AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 1-25/173
MARKERS OF DISEASE-ACTIVITY - LABORATORY MARKERS
Authors: HARTUNG HP
Citation: Hp. Hartung, MARKERS OF DISEASE-ACTIVITY - LABORATORY MARKERS, European journal of neurology, 5, 1998, pp. 17-17
GUILLAIN-BARRE-SYNDROME, CIDP AND OTHER CHRONIC IMMUNE-MEDIATED NEUROPATHIES
Authors: HARTUNG HP VANDERMECHE FGA POLLARD JD
Citation: Hp. Hartung et al., GUILLAIN-BARRE-SYNDROME, CIDP AND OTHER CHRONIC IMMUNE-MEDIATED NEUROPATHIES, Current opinion in neurology, 11(5), 1998, pp. 497-513
DEMYELINATING INFLAMMATORY NEUROPATHIES, INCLUDING GUILLAIN-BARRE-SYNDROME
Authors: STECK AJ SCHAERENWIEMERS N HARTUNG HP
Citation: Aj. Steck et al., DEMYELINATING INFLAMMATORY NEUROPATHIES, INCLUDING GUILLAIN-BARRE-SYNDROME, Current opinion in neurology, 11(4), 1998, pp. 311-318
MICROGLIA AND MACROPHAGES ARE MAJOR SOURCES OF LOCALLY PRODUCED TRANSFORMING-GROWTH-FACTOR BETA(1) AFTER TRANSIENT MIDDLE CEREBRAL-ARTERY OCCLUSION IN RATS
Authors: LEHRMANN E KIEFER R CHRISTENSEN T TOYKA KV ZIMMER J DIEMER NH HARTUNG HP FINSEN B
Citation: E. Lehrmann et al., MICROGLIA AND MACROPHAGES ARE MAJOR SOURCES OF LOCALLY PRODUCED TRANSFORMING-GROWTH-FACTOR BETA(1) AFTER TRANSIENT MIDDLE CEREBRAL-ARTERY OCCLUSION IN RATS, Glia (New York, N.Y. : Print), 24(4), 1998, pp. 437-448
CLONING AND EXPRESSION OF THE CAMPYLOBACTER-JEJUNI LON GENE DETECTED BY RNA ARBITRARILY PRIMED PCR
Authors: THIES FL HARTUNG HP GIEGERICH G
Citation: Fl. Thies et al., CLONING AND EXPRESSION OF THE CAMPYLOBACTER-JEJUNI LON GENE DETECTED BY RNA ARBITRARILY PRIMED PCR, FEMS microbiology letters, 165(2), 1998, pp. 329-334
ELECTROPHYSIOLOGICAL CLASSIFICATION OF GUILLAIN-BARRE-SYNDROME - CLINICAL ASSOCIATIONS AND OUTCOME
Authors: HADDEN RDM CORNBLATH DR HUGHES RAC ZIELASEK J HARTUNG HP TOYKA KV SWAN AV
Citation: Rdm. Hadden et al., ELECTROPHYSIOLOGICAL CLASSIFICATION OF GUILLAIN-BARRE-SYNDROME - CLINICAL ASSOCIATIONS AND OUTCOME, Annals of neurology, 44(5), 1998, pp. 780-788
EXPRESSION OF INTEGRINS IN EXPERIMENTAL AUTOIMMUNE NEURITIS AND GUILLAIN-BARRE-SYNDROME
Authors: PREVITALI SC ARCHELOS JJ HARTUNG HP
Citation: Sc. Previtali et al., EXPRESSION OF INTEGRINS IN EXPERIMENTAL AUTOIMMUNE NEURITIS AND GUILLAIN-BARRE-SYNDROME, Annals of neurology, 44(4), 1998, pp. 611-621
MATRIX METALLOPROTEINASES MMP-9 AND MMP-7 ARE EXPRESSED IN EXPERIMENTAL AUTOIMMUNE NEURITIS AND THE GUILLAIN-BARRE-SYNDROME
Authors: KIESEIER BC CLEMENTS JM PISCHEL HB WELLS GMA MILLER K GEARING AJH HARTUNG HP
Citation: Bc. Kieseier et al., MATRIX METALLOPROTEINASES MMP-9 AND MMP-7 ARE EXPRESSED IN EXPERIMENTAL AUTOIMMUNE NEURITIS AND THE GUILLAIN-BARRE-SYNDROME, Annals of neurology, 43(4), 1998, pp. 427-434
ISOLATION AND CHARACTERIZATION OF AN OLIGODENDROCYTE PRECURSOR-DERIVED B-CELL EPITOPE IN MULTIPLE-SCLEROSIS
Authors: ARCHELOS JJ TROTTER J PREVITALI S WEISSBRICH B TOYKA KV HARTUNG HP
Citation: Jj. Archelos et al., ISOLATION AND CHARACTERIZATION OF AN OLIGODENDROCYTE PRECURSOR-DERIVED B-CELL EPITOPE IN MULTIPLE-SCLEROSIS, Annals of neurology, 43(1), 1998, pp. 15-24
PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS
Authors: KAPPOS L POLMAN C POZZILLI C THOMPSON A DAHLKE F KNIGHT R HERN J COLEMAN R GERRIE L COOPER G MOORE J BORINGA J VANOOSTEN B RONNER H SCHRIJVER H TRUYEN L MONTALBAN J RIO J TINTORE M JACAS C MARZO E LECHNERSCOTT J HUBER S LIENERT C BRUNNSCHWEILER H HAWKINS S DROOGAN A MCDONNELL G DUDDY M MCKINSTRY S ALTENKIRCH H BAUM K EINHAUPL K MARX P POEWE W WALTER G AKMAN H BROCKMEIER B SCHERER P ZSCHENDERLEIN R SCHMIERER K GELDERBLOM H HARTMANN A STAPF C LUSCHOW A MACKERT B SCHUMACHER H MASUHR F HEMPEL T ZIMMERMANN R MUNCH M FRANCIS D HEAFIELD M ALMEMAR A WINER J CHONG M BROCHET B GAYOU A AURIACOMBE S DOUSSET V WILES C THOMAS F PICKERSGILL T HINDS N DAWSON K HUGHES T HUTCHINSON M MURPHY R REDMOND J WEBB S STOLL G JANDER S HAGEMANN G KOLLER H HANEMANN C KOLMEL H REICHEL D PETEREIT K THIEME A KHATAMI A NEUMANN M AMADUCCI L MASSACESI L SIRACUSA G AMATO M BARTOLOZZI L REPICE A MINDERHOUD J DEKEYSER J ZORGDRAGER A ZWANIKKEN C POSER S POLAK T GUNTHER A BITSCH A BORNER T WEBER F WIKSTROM J FARKKILA M MAJURI H SUMELAHTI M TELAKIVI T FREDRIKSON S MARTIN C MILLER D ORIORDAN J BREX P KAPOOR R WERRING D CONFAVREUX C BRUNET P HANNOUN D BRUDON F MOREAU T BLANC S DHOOGHE M JACOBS K LISSOIR F DEMONTY L COMI G COLOMBO B ROSSI P RODEGHER M SANTUCCIO G MARTINELLI F HOHLFELD R WALTHER E GOEBELS N DANG T LINDERT R VOLTZ R CARTLIDGE N BATES D MORAN G PANDIT L WESTWOOD M HALLER P SOMMER J BITTER J SUSS F MELLIES J MUCHA P LYONCAEN O DEGOS JD ROULLET E LUBETZKI C CREANGE A TOURBAH A PEZ D LECANUET P NICOLT P EDAN G BELLIARD S DEMARCO O CAHAGNE V DEBURGHGRAEVE V BRUNET I FIESCHI C MILLEFIORINI E GASPERINI C BUTTINELLI C FRONTINI M HOWELL S HADJIVASSILIOU M GIBSON A GRAHAM A HARKNESS K LAWDEN M CLANET M WAUBAN E AZAISVUILLEMIN C LAU G LOUIS C PANELIUS M RUUTIAINEN J ERALINNA J SOILUHANNINEN M GOLD R HARTUNG HP JUNG S BAYAS A FLACHENECKER P WEILBACH F ARCHELOS J KOLLEGGER H VASS K ASENBAUM S CHATSAKOS T BECKMANN K GHAZI M WAGNER K MILTENBURGER C MCFARLAND H PETKAU J SABOURAUD O TOYKA K
Citation: L. Kappos et al., PLACEBO-CONTROLLED MULTICENTER RANDOMIZED TRIAL OF INTERFERON BETA-1BIN TREATMENT OF SECONDARY PROGRESSIVE MULTIPLE-SCLEROSIS, Lancet, 352(9139), 1998, pp. 1491-1497
RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF INTERFERON BETA-1A IN RELAPSING REMITTING MULTIPLE-SCLEROSIS/
Authors: EBERS GC RICE G LESAUX J PATY D OGER J LI DKB BEALL S DEVONSHIRE V HASHIMOTO S HOOGE J KASTRUKOFF L KRIEGER C MEZEI M SELAND P VOROBEYCHI G MORRISON W NELSON J FREEDMAN MS CHRISIE S NELSON R RABINOVITCH H FREEDMAN C HARTUNG HP RIECKMANN P ARCHELOS J JUNG S WEILBACH F FLACHENECKE P SAUER J HOMMES O JONGEN P BROUWER S MCLEOD J POLLARD J NG R SANDBERGWOLLHEIM M KALLEN K NILSSON P EKBERG R LUNDGREN A JADBACK G WIKSTROM J MULTANEN J VALJAKKA M CARTON H LISSOIR F DECLERQ I VIEREN M PEETERS E DUBOIS B DEKEERSMAEKER E VANHERLE A HUGHES RAC SHARRACK B SOUDAIN S PANELIUS M ERALINNA J SOILUHANNINEN M MURTO S MEDAER R BROECKX J VANROOSE E BOGAERS A BLUMHARDT LD EDWARDS S LIU C ORPE V BARNES D SCHWARTZ M STOY N HARRAGHY C BERTELSMANN F UITDEHAAG B NASSERI K CHOFFLON M ROTH S KAPPOS L HUBER S BELLAICHE Y SENN C KING J JUBERT J WHITTEN S NEWSOMDAVIS JM PALACE J LEE M EVANGELOU N PINTO A CAVEY A SINDIC CJM MONTEYNE P VEROUGSTRAETE D VANDOORN PA MOLL W VISSER L WILLEMS M MARTINA I BULJEVAC D LOMAN L BATES D PANDIT D IRVING J RHODES B RIDDEHOUGH A ZHAO GJ WANG X CHENG Y AMMOURY N DUPONT F GALAZKA A HYDE R OLSON M PERNIN MO ABDULAHAD AK HOMMES O NOSEWORTHY J BORDEN E OBRIEN P WOLINSKY J
Citation: Gc. Ebers et al., RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF INTERFERON BETA-1A IN RELAPSING REMITTING MULTIPLE-SCLEROSIS/, Lancet, 352(9139), 1998, pp. 1498-1504
PARAOXONASE PON1 POLYMORPHISM LEU-MET54 IS ASSOCIATED WITH CAROTID ATHEROSELEROSIS - RESULTS OF THE AUSTRIAN STROKE PREVENTION STUDY
Authors: SCHMIDT H SCHMIDT R NIEDERKORN K GRADERT A SCHUMACHER M WATZINGER N HARTUNG HP KOSTNER GM
Citation: H. Schmidt et al., PARAOXONASE PON1 POLYMORPHISM LEU-MET54 IS ASSOCIATED WITH CAROTID ATHEROSELEROSIS - RESULTS OF THE AUSTRIAN STROKE PREVENTION STUDY, Stroke, 29(10), 1998, pp. 2043-2048
MATRIX METALLOPROTEINASES ARE EXPRESSED IN EXPERIMENTAL AUTOIMMUNE NEURITIS AND THE GUILLAIN-BARRE-SYNDROME
Authors: KIESEIER BC CLEMENTS JM GEARING AJH TOYKA KV HARTUNG HP
Citation: Bc. Kieseier et al., MATRIX METALLOPROTEINASES ARE EXPRESSED IN EXPERIMENTAL AUTOIMMUNE NEURITIS AND THE GUILLAIN-BARRE-SYNDROME, Neurology, 50(4), 1998, pp. 5081-5081
A 3-YEAR FOLLOW-UP-STUDY ON MRI WHITE-MATTER HYPERINTENSITIES IN NORMAL PERSONS - RATE, PREDICTORS, AND NEUROPSYCHOLOGIC CONSEQUENCES OF PROGRESSION
Authors: SCHMIDT R FAZEKAS F KAPELLER P SCHMIDT H ROOB G HARTUNG HP
Citation: R. Schmidt et al., A 3-YEAR FOLLOW-UP-STUDY ON MRI WHITE-MATTER HYPERINTENSITIES IN NORMAL PERSONS - RATE, PREDICTORS, AND NEUROPSYCHOLOGIC CONSEQUENCES OF PROGRESSION, Neurology, 50(4), 1998, pp. 70006-70006
INTRAVENOUS IMMUNOGLOBULIN IN THE TREATME NT OF INTERMITTENT MULTIPLE-SCLEROSIS - AN UPDATE
Authors: FAZEKAS F STRASSERFUCHS S HARTUNG HP
Citation: F. Fazekas et al., INTRAVENOUS IMMUNOGLOBULIN IN THE TREATME NT OF INTERMITTENT MULTIPLE-SCLEROSIS - AN UPDATE, Nervenarzt, 69(4), 1998, pp. 361-365
MULTIPLE-SCLEROSIS - PROMOTION OF REMYELINATION AS A FUTURE THERAPEUTIC STRATEGY
Authors: POHLAU D AKTAS O EPPLEN C HARTUNG HP HOFFMANN V PRZUNTEK H
Citation: D. Pohlau et al., MULTIPLE-SCLEROSIS - PROMOTION OF REMYELINATION AS A FUTURE THERAPEUTIC STRATEGY, Nervenarzt, 69(10), 1998, pp. 841-850
ROLE OF THE LEUKOCYTE-ADHESION MOLECULE L-SELECTIN IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
Authors: ARCHELOS JJ JUNG S RINNER W LASSMANN H MIYASAKA M HARTUNG HP
Citation: Jj. Archelos et al., ROLE OF THE LEUKOCYTE-ADHESION MOLECULE L-SELECTIN IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, Journal of the neurological sciences, 159(2), 1998, pp. 127-134
INTRAVENOUS IMMUNOGLOBULIN TREATMENT OF NEUROLOGICAL AUTOIMMUNE-DISEASES
Authors: STANGEL M HARTUNG HP MARX P GOLD R
Citation: M. Stangel et al., INTRAVENOUS IMMUNOGLOBULIN TREATMENT OF NEUROLOGICAL AUTOIMMUNE-DISEASES, Journal of the neurological sciences, 153(2), 1998, pp. 203-214
SEQUENTIAL EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA-1 BY T-CELLS, MACROPHAGES, AND MICROGLIA IN RAT SPINAL-CORD DURING AUTOIMMUNE INFLAMMATION
Authors: KIEFER R SCHWEITZER T JUNG S TOYKA KV HARTUNG HP
Citation: R. Kiefer et al., SEQUENTIAL EXPRESSION OF TRANSFORMING GROWTH-FACTOR-BETA-1 BY T-CELLS, MACROPHAGES, AND MICROGLIA IN RAT SPINAL-CORD DURING AUTOIMMUNE INFLAMMATION, Journal of neuropathology and experimental neurology, 57(5), 1998, pp. 385-395
CORRELATING IMMUNOLOGICAL AND MAGNETIC-RESONANCE-IMAGING MARKERS OF DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS
Authors: GIOVANNONI G KIESEIER B HARTUNG HP
Citation: G. Giovannoni et al., CORRELATING IMMUNOLOGICAL AND MAGNETIC-RESONANCE-IMAGING MARKERS OF DISEASE-ACTIVITY IN MULTIPLE-SCLEROSIS, Journal of Neurology, Neurosurgery and Psychiatry, 64, 1998, pp. 31-36
THE MET-LEU54 POLYMORPHISM IS ASSOCIATED WITH PROGRESSION OF MICROANGIOPATHY-RELATED CEREBRAL ABNORMALITIES (MARCA)ON MRI - 3-YEAR FOLLOW-UP RESULTS OF THE AUSTRIAN STROKE PREVENTION STUDY
Authors: SCHMIDT H REINHOL S FAZEKAS F SCHUMACHER M KAPELLER P WATZINGER N HARTUNG HP KOSTNER GM
Citation: H. Schmidt et al., THE MET-LEU54 POLYMORPHISM IS ASSOCIATED WITH PROGRESSION OF MICROANGIOPATHY-RELATED CEREBRAL ABNORMALITIES (MARCA)ON MRI - 3-YEAR FOLLOW-UP RESULTS OF THE AUSTRIAN STROKE PREVENTION STUDY, Circulation, 98(17), 1998, pp. 149-149
THE ROLE OF THE VERY LATE ANTIGEN-4 AND ITS COUNTERLIGAND VASCULAR CELL-ADHESION MOLECULE-1 IN THE PATHOGENESIS OF EXPERIMENTAL AUTOIMMUNE NEURITIS OF THE LEWIS RAT
Authors: ENDERS U LOBB R PEPINSKY RB HARTUNG HP TOYKA KV GOLD R
Citation: U. Enders et al., THE ROLE OF THE VERY LATE ANTIGEN-4 AND ITS COUNTERLIGAND VASCULAR CELL-ADHESION MOLECULE-1 IN THE PATHOGENESIS OF EXPERIMENTAL AUTOIMMUNE NEURITIS OF THE LEWIS RAT, Brain (Print), 121, 1998, pp. 1257-1266
MACROPHAGE DIFFERENTIATION ANTIGENS IN ACUTE AND CHRONIC AUTOIMMUNE POLYNEUROPATHIES
Authors: KIEFER R KIESEIER BC BRUCK W HARTUNG HP TOYKA KV
Citation: R. Kiefer et al., MACROPHAGE DIFFERENTIATION ANTIGENS IN ACUTE AND CHRONIC AUTOIMMUNE POLYNEUROPATHIES, Brain, 121, 1998, pp. 469-479
MATRIX METALLOPROTEINASE-9 AND METALLOPROTEINASE-7 ARE REGULATED IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS
Authors: KIESEIER BC KIEFER R CLEMENTS JM MILLER K WELLS GMA SCHWEITZER T GEARING AJH HARTUNG HP
Citation: Bc. Kieseier et al., MATRIX METALLOPROTEINASE-9 AND METALLOPROTEINASE-7 ARE REGULATED IN EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS, Brain, 121, 1998, pp. 159-166
THE ROLE OF ADHESION MOLECULES IN MULTIPLE-SCLEROSIS - BIOLOGY, PATHOGENESIS AND THERAPEUTIC IMPLICATIONS
Authors: ARCHELOS JJ HARTUNG HP
Citation: Jj. Archelos et Hp. Hartung, THE ROLE OF ADHESION MOLECULES IN MULTIPLE-SCLEROSIS - BIOLOGY, PATHOGENESIS AND THERAPEUTIC IMPLICATIONS, Molecular medicine today, 3(7), 1997, pp. 310-321
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>